Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil vs LMWH in Fetal Growth Restriction
NCT03230162Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Jun 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ASP-001 in fetal growth restriction (FGR), sponsored by Ain Shams University. Primary endpoint: Neonatal birth weight. Status: unknown.
02
Drugs
ASP-001
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT03230162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03230162.